A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 38,276 shares of TMO stock, worth $19.8 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
38,276
Previous 111,086 65.54%
Holding current value
$19.8 Million
Previous $61.4 Million 61.46%
% of portfolio
0.13%
Previous 0.28%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$531.86 - $624.21 $38.7 Million - $45.4 Million
-72,810 Reduced 65.54%
38,276 $23.7 Million
Q2 2024

Aug 09, 2024

BUY
$541.52 - $599.02 $45.5 Million - $50.4 Million
84,112 Added 311.83%
111,086 $61.4 Million
Q1 2024

May 09, 2024

BUY
$528.82 - $599.43 $14 Million - $15.9 Million
26,465 Added 5199.41%
26,974 $15.7 Million
Q4 2023

Feb 09, 2024

SELL
$431.41 - $532.94 $2.06 Million - $2.55 Million
-4,783 Reduced 90.38%
509 $270,000
Q3 2023

Nov 13, 2023

BUY
$498.29 - $574.41 $2.64 Million - $3.04 Million
5,292 New
5,292 $2.68 Million
Q1 2023

May 09, 2023

SELL
$535.0 - $604.82 $26.5 Million - $29.9 Million
-49,508 Reduced 98.29%
861 $496,000
Q4 2022

Feb 10, 2023

BUY
$484.71 - $571.37 $2.21 Million - $2.6 Million
4,550 Added 9.93%
50,369 $27.7 Million
Q3 2022

Nov 10, 2022

SELL
$507.19 - $604.49 $768,392 - $915,802
-1,515 Reduced 3.2%
45,819 $23.2 Million
Q2 2022

Aug 05, 2022

SELL
$500.9 - $612.21 $2.24 Million - $2.74 Million
-4,472 Reduced 8.63%
47,334 $25.7 Million
Q1 2022

May 12, 2022

BUY
$524.0 - $644.92 $4.94 Million - $6.09 Million
9,437 Added 22.27%
51,806 $30.6 Million
Q4 2021

Feb 10, 2022

SELL
$569.0 - $667.24 $9.74 Million - $11.4 Million
-17,114 Reduced 28.77%
42,369 $28.3 Million
Q3 2021

Nov 12, 2021

BUY
$509.53 - $609.78 $7.02 Million - $8.4 Million
13,774 Added 30.13%
59,483 $34 Million
Q2 2021

Aug 12, 2021

SELL
$441.0 - $508.24 $606,816 - $699,338
-1,376 Reduced 2.92%
45,709 $23.1 Million
Q1 2021

May 13, 2021

BUY
$439.85 - $518.83 $19.6 Million - $23.1 Million
44,566 Added 1769.19%
47,085 $21.5 Million
Q4 2020

Feb 16, 2021

SELL
$435.06 - $527.66 $14.9 Million - $18.1 Million
-34,355 Reduced 93.17%
2,519 $1.17 Million
Q3 2020

Nov 12, 2020

BUY
$359.77 - $441.52 $1.08 Million - $1.32 Million
2,989 Added 8.82%
36,874 $16.3 Million
Q2 2020

Aug 13, 2020

BUY
$275.2 - $362.34 $3.81 Million - $5.02 Million
13,860 Added 69.21%
33,885 $12.3 Million
Q1 2020

May 13, 2020

BUY
$255.3 - $340.05 $3.47 Million - $4.62 Million
13,575 Added 210.47%
20,025 $5.68 Million
Q4 2019

Feb 12, 2020

BUY
$271.93 - $328.04 $1.75 Million - $2.12 Million
6,450 New
6,450 $2.1 Million
Q2 2018

Aug 02, 2018

SELL
$203.14 - $219.53 $2.03 Million - $2.19 Million
-9,975 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$192.98 - $224.11 $3.71 Million - $4.31 Million
-19,225 Reduced 65.84%
9,975 $2.06 Million
Q4 2017

Feb 09, 2018

SELL
$182.03 - $200.37 $4.96 Million - $5.46 Million
-27,225 Reduced 48.25%
29,200 $5.54 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $7.83 Million - $8.84 Million
45,575 Added 420.05%
56,425 $10.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
10,850
10,850 $1.89 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $202B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.